Carrimycin

DRUG3 trials

Sponsors

Beijing YouAn Hospital, Shanghai Jiao Tong University School of Medicine, Shenyang Tonglian Group CO., Ltd

Conditions

Coronavirus Disease 2019Head and Neck Squamous Cell CarcinomaNovel Coronavirus Infectious Disease (COVID-19)Oral Squamous Cell Carcinoma

Phase 1

Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial

CompletedNCT04413214

Shanghai Jiao Tong University School of MedicineHead and Neck Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma

Start: 2019-12-20End: 2022-12-30Updated: 2023-04-05

Phase 3

Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients

TerminatedNCT04672564

Shenyang Tonglian Group CO., LtdCoronavirus Disease 2019

Start: 2021-03-30End: 2022-05-09Updated: 2023-02-23

Phase 4

The Clinical Study of Carrimycin on Treatment Patients With COVID-19

Beijing YouAn HospitalNovel Coronavirus Infectious Disease (COVID-19)

Start: 2020-02-23End: 2021-02-28Target: 520Updated: 2020-02-27